RAPT Therapeutics (RAPT) Free Cash Flow (2018 - 2025)
RAPT Therapeutics (RAPT) free cash flow from Sep 30, 2018 to Sep 30, 2025. The TTM RAPT Therapeutics (RAPT) free cash flow is -$87M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
RAPT Therapeutics (RAPT) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -14.03% |
| 3 Years TTM | +7.48% |
| 5 Years TTM | +22.77% |
| All Time TTM | +18.91% |
Annual Free Cash Flow change of RAPT Therapeutics (RAPT)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$76M | -8.63% |
| 2024 | -$83M | -15.03% |
| 2023 | -$98M | +37.08% |
| 2022 | -$72M | +15.91% |
| 2021 | -$62M | +51.11% |
| 2020 | -$41M | +12.46% |
| 2019 | -$36M | -0.25% |
| 2018 | -$36M | N/A |
Comparison RAPT Therapeutics (RAPT) five years free cash flow CAGR with competitors
RAPT Therapeutics (RAPT) five years free cash flow CAGR is 22.78%.